Page last updated: 2024-11-06

fenclorac

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Fenclorac is a non-steroidal anti-inflammatory drug (NSAID) with analgesic and anti-inflammatory properties. It is a derivative of chloroacetic acid and exhibits its effects by inhibiting the cyclooxygenase (COX) enzyme, thereby reducing the production of prostaglandins, which are involved in inflammation and pain. Fenclorac has been studied for its potential use in treating rheumatoid arthritis, osteoarthritis, and other inflammatory conditions. Its synthesis involves a multi-step process starting with the reaction of chloroacetic acid with a suitable aromatic amine, followed by a series of chemical transformations. Despite showing promise in preclinical studies, Fenclorac has not gained widespread clinical use due to concerns about its potential for gastrointestinal side effects. Further research is needed to evaluate its long-term safety and efficacy, and to develop alternative formulations that minimize adverse effects.'

fenclorac: structure; RN given refers to cpd without isomeric designation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID37494
CHEMBL ID1614638
SCHEMBL ID24314
MeSH IDM0061342

Synonyms (28)

Synonym
fencloracum [inn-latin]
benzeneacetic acid, alpha,3-dichloro-4-cyclohexyl-
alpha,3-dichloro-4-cyclohexylbenzeneacetic acid
acetic acid, 2-chloro-2-(3-chloro-4-cyclohexylphenyl)-
brn 1995348
fenclorac [usan:inn]
whr 539
chloro(3-chloro-4-cyclohexylphenyl)acetic acid
fencloraco [inn-spanish]
36616-52-1
D04144
fenclorac (usan/inn)
fenclorac
whr-539
2-chloro-2-(3-chloro-4-cyclohexylphenyl)acetic acid
CHEMBL1614638
5458s22s8i ,
fencloraco
fencloracum
unii-5458s22s8i
fenclorac [inn]
fenclorac [usan]
SCHEMBL24314
alpha,3-dichloro-4-cyclohexylphenylacetic acid
GXEUNRBWEAIPCN-UHFFFAOYSA-N
DTXSID50865828
Q27261169
AKOS040746824

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
"A rapid stability-indicating GLC method is described for the determination of fenclorac as the diethylamine salt in dosage formulations."( GLC assay for fenclorac.
Patel, DM; Reavey-Cantwell, NH; Visalli, AJ, 1976
)
0.84
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID540230Dose normalised AUC in rat after po administration2005Xenobiotica; the fate of foreign compounds in biological systems, Feb, Volume: 35, Issue:2
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
AID540231Dose normalised AUC in dog after po administration2005Xenobiotica; the fate of foreign compounds in biological systems, Feb, Volume: 35, Issue:2
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
AID540233Dose normalised AUC in human after po administration2005Xenobiotica; the fate of foreign compounds in biological systems, Feb, Volume: 35, Issue:2
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
AID540232Dose normalised AUC in monkey after po administration2005Xenobiotica; the fate of foreign compounds in biological systems, Feb, Volume: 35, Issue:2
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (87.50)18.7374
1990's0 (0.00)18.2507
2000's1 (12.50)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.94

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.94 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.14 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.94)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other8 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]